Cargando…
In Silico Food-Drug Interaction: A Case Study of Eluxadoline and Fatty Meal
Food-drug interaction is an infrequently considered aspect in clinical practice. Usually, drugs are taken together with meals and what follows may adversely affect pharmacokinetic and pharmacodynamic properties, and hence, the therapeutic effects. In this study, a computational protocol was proposed...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7731208/ https://www.ncbi.nlm.nih.gov/pubmed/33266221 http://dx.doi.org/10.3390/ijms21239127 |
_version_ | 1783621853482319872 |
---|---|
author | Maruca, Annalisa Lupia, Antonio Rocca, Roberta Keszthelyi, Daniel Corsetti, Maura Alcaro, Stefano |
author_facet | Maruca, Annalisa Lupia, Antonio Rocca, Roberta Keszthelyi, Daniel Corsetti, Maura Alcaro, Stefano |
author_sort | Maruca, Annalisa |
collection | PubMed |
description | Food-drug interaction is an infrequently considered aspect in clinical practice. Usually, drugs are taken together with meals and what follows may adversely affect pharmacokinetic and pharmacodynamic properties, and hence, the therapeutic effects. In this study, a computational protocol was proposed to explain the different assimilations of two µ-receptors agonists, eluxadoline and loperamide, with a peculiar pharmacokinetic profile. Compared to loperamide, eluxadoline is absorbed less after the intake of a fatty meal, and the LogP values do not explain this event. Firstly, keeping in mind the different pH in the intestinal tract, the protonation states of both compounds were calculated. Then, all structures were subjected to a conformational search by using MonteCarlo and Molecular Dynamics methods, with solvation terms mimicking the water and weak polar solvent (octanol). Both computational results showed that eluxadoline has less conformational freedom in octanol, unlike loperamide, which exhibits constant behavior in both solvents. Therefore, we hypothesize that fatty meal causes the “closure” of the eluxadoline molecule to prevent the exposure of the polar groups and their interaction with water, necessary for the drug absorption. Based on our results, this work could be a reasonable “case study”, useful for future investigation of the drug pharmacokinetic profile. |
format | Online Article Text |
id | pubmed-7731208 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-77312082020-12-12 In Silico Food-Drug Interaction: A Case Study of Eluxadoline and Fatty Meal Maruca, Annalisa Lupia, Antonio Rocca, Roberta Keszthelyi, Daniel Corsetti, Maura Alcaro, Stefano Int J Mol Sci Article Food-drug interaction is an infrequently considered aspect in clinical practice. Usually, drugs are taken together with meals and what follows may adversely affect pharmacokinetic and pharmacodynamic properties, and hence, the therapeutic effects. In this study, a computational protocol was proposed to explain the different assimilations of two µ-receptors agonists, eluxadoline and loperamide, with a peculiar pharmacokinetic profile. Compared to loperamide, eluxadoline is absorbed less after the intake of a fatty meal, and the LogP values do not explain this event. Firstly, keeping in mind the different pH in the intestinal tract, the protonation states of both compounds were calculated. Then, all structures were subjected to a conformational search by using MonteCarlo and Molecular Dynamics methods, with solvation terms mimicking the water and weak polar solvent (octanol). Both computational results showed that eluxadoline has less conformational freedom in octanol, unlike loperamide, which exhibits constant behavior in both solvents. Therefore, we hypothesize that fatty meal causes the “closure” of the eluxadoline molecule to prevent the exposure of the polar groups and their interaction with water, necessary for the drug absorption. Based on our results, this work could be a reasonable “case study”, useful for future investigation of the drug pharmacokinetic profile. MDPI 2020-11-30 /pmc/articles/PMC7731208/ /pubmed/33266221 http://dx.doi.org/10.3390/ijms21239127 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Maruca, Annalisa Lupia, Antonio Rocca, Roberta Keszthelyi, Daniel Corsetti, Maura Alcaro, Stefano In Silico Food-Drug Interaction: A Case Study of Eluxadoline and Fatty Meal |
title | In Silico Food-Drug Interaction: A Case Study of Eluxadoline and Fatty Meal |
title_full | In Silico Food-Drug Interaction: A Case Study of Eluxadoline and Fatty Meal |
title_fullStr | In Silico Food-Drug Interaction: A Case Study of Eluxadoline and Fatty Meal |
title_full_unstemmed | In Silico Food-Drug Interaction: A Case Study of Eluxadoline and Fatty Meal |
title_short | In Silico Food-Drug Interaction: A Case Study of Eluxadoline and Fatty Meal |
title_sort | in silico food-drug interaction: a case study of eluxadoline and fatty meal |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7731208/ https://www.ncbi.nlm.nih.gov/pubmed/33266221 http://dx.doi.org/10.3390/ijms21239127 |
work_keys_str_mv | AT marucaannalisa insilicofooddruginteractionacasestudyofeluxadolineandfattymeal AT lupiaantonio insilicofooddruginteractionacasestudyofeluxadolineandfattymeal AT roccaroberta insilicofooddruginteractionacasestudyofeluxadolineandfattymeal AT keszthelyidaniel insilicofooddruginteractionacasestudyofeluxadolineandfattymeal AT corsettimaura insilicofooddruginteractionacasestudyofeluxadolineandfattymeal AT alcarostefano insilicofooddruginteractionacasestudyofeluxadolineandfattymeal |